Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Autoimmune Diseases × telitacicept × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 2 Neuromuscular Diseases 1 Autoimmune Diseases 1

Interventions

telitacicept 1 Vitamin D 1 Population Groups 1 Music Therapy 1 Fish Oils 1 Fatty Acids, Omega-3 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06827587 2025-02-14

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase NA Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis, Neuromuscular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡